Please provide your email address to receive an email when new articles are posted on . Data were derived from Carr WW, et al. Abstract 043. Presented at: AAAAI Annual Meeting; Feb. 24-27, 2023; San ...

DUBLIN--(BUSINESS WIRE)--The "Global Allergic Rhinitis Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering. The research provides insights into ...

<0> Research and MarketsLaura Wood, Senior ManagerFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax ...

MISSOULA, Mont., Jan. 7, 2026 /PRNewswire/ -- Inimmune Corporation ("Inimmune"), a clinical-stage biotechnology company focused on developing innovative immunotherapies, today announced the start of ...

Please provide your email address to receive an email when new articles are posted on . Black patients are 46% less likely than white patients to receive sublingual immunotherapy prescriptions for ...

The surveys and clinical trials reviewed here investigated patients' symptomatology and experiences with AR treatment among 11,046 patients and healthcare providers in 9 countries. Patients with AR ...

The importance of the above prevalence data cannot be underestimated. These data translate into annual direct costs of $3.4 billion and an additional $1.93 billion in indirect costs (lost work ...

Patients treated with Odactra experienced a 22% reduction in total combined rhinitis score compared with placebo. The expanded approval was supported by data from a phase 3 trial (ClinicalTrials.gov ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

HealthDay News — Allergic rhinitis (AR) constitutes a considerable burden, with patients at increased risk for asthma and various mental health comorbidities, according to a study published online ...

According to a new study, immunotherapy for allergy sufferers reduced symptoms by 55% after 3 years and reduced the amount of medication needed for symptom relief by 64%. According to a new study, ...

DUBLIN--(BUSINESS WIRE)--The "Europe Allergic Rhinitis Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering. The research provides insights into ...